CRWD is trading 4.1% down now at $186.65 as investors reassess valuation after its recent multi-day rally and stock split momentum.
- Morgan Stanley and UBS issued price-target adjustments, adding pressure to the share price.
- Broader tech weakness and profit-taking in high-multiple AI and security names are weighing on the stock.
- The decline comes despite solid underlying business performance.